Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.71 - $2.57 $33,687 - $50,629
19,700 New
19,700 $45,000
Q4 2022

Feb 14, 2023

BUY
$5.88 - $12.03 $541,548 - $1.11 Million
92,100 Added 451.47%
112,500 $1.35 Million
Q3 2022

Nov 14, 2022

SELL
$4.6 - $9.91 $80,960 - $174,416
-17,600 Reduced 46.32%
20,400 $132,000
Q2 2022

Aug 15, 2022

SELL
$3.72 - $9.0 $117,924 - $285,300
-31,700 Reduced 45.48%
38,000 $174,000
Q1 2022

May 16, 2022

BUY
$8.19 - $13.89 $20,475 - $34,725
2,500 Added 3.72%
69,700 $603,000
Q4 2021

Feb 14, 2022

SELL
$12.98 - $29.75 $1.4 Million - $3.22 Million
-108,100 Reduced 61.67%
67,200 $960,000
Q3 2021

Nov 15, 2021

BUY
$12.13 - $23.82 $1.19 Million - $2.33 Million
98,000 Added 126.78%
175,300 $3.85 Million
Q2 2021

Aug 11, 2021

BUY
$8.34 - $14.59 $78,396 - $137,146
9,400 Added 13.84%
77,300 $1.03 Million
Q1 2021

May 17, 2021

BUY
$4.22 - $11.33 $162,470 - $436,205
38,500 Added 130.95%
67,900 $690,000
Q4 2020

Feb 16, 2021

BUY
$2.48 - $4.64 $14,880 - $27,839
6,000 Added 25.64%
29,400 $125,000
Q3 2020

Nov 16, 2020

SELL
$2.58 - $4.16 $62,952 - $101,504
-24,400 Reduced 51.05%
23,400 $61,000
Q2 2020

Aug 14, 2020

SELL
$2.87 - $4.12 $18,655 - $26,780
-6,500 Reduced 11.97%
47,800 $169,000
Q1 2020

May 15, 2020

BUY
$2.6 - $5.5 $19,760 - $41,800
7,600 Added 16.27%
54,300 $165,000
Q4 2019

Feb 14, 2020

BUY
$2.43 - $5.74 $113,481 - $268,058
46,700 New
46,700 $241,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $86.6M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.